Surveillance for human immunodeficiency virus type 1 group O infections in the United States

Transfusion ◽  
1996 ◽  
Vol 36 (5) ◽  
pp. 398-400 ◽  
Author(s):  
CP Pau ◽  
DJ Hu ◽  
C Spruill ◽  
C Schable ◽  
E Lackritz ◽  
...  
Keyword(s):  
United States ◽  
Human Immunodeficiency Virus ◽  
Human Immunodeficiency Virus Type ◽  
Virus Type ◽  
The United States ◽  
Immunodeficiency Virus

scholarly journals Extent of Cross-Resistance between Agents Used To Treat Human Immunodeficiency Virus Type 1 Infection in Clinically Derived Isolates

2002 ◽  
Vol 46 (3) ◽  
pp. 909-912 ◽  
Author(s):  
P. Richard Harrigan ◽  
Brendan A. Larder
Keyword(s):  
United States ◽  
Human Immunodeficiency Virus ◽  
Human Immunodeficiency Virus Type ◽  
Virus Type ◽  
The United States ◽  
Cross Resistance ◽  
Antiretroviral Agents ◽  
Immunodeficiency Virus

ABSTRACT The phenomenon of cross-resistance to antiretroviral agents used to treat human immunodeficiency virus type 1 infection is well known but so far has been only qualitatively described. Here, we quantitate the degree of cross-resistance among all commonly prescribed antiretroviral agents in almost 5,000 clinically derived recombinant isolates collected in the United States since January 2000.

Sign in / Sign up

Export Citation Format

Share Document